0001676568-17-000001.txt : 20170104
0001676568-17-000001.hdr.sgml : 20170104
20170104113131
ACCESSION NUMBER: 0001676568-17-000001
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161231
FILED AS OF DATE: 20170104
DATE AS OF CHANGE: 20170104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARGOS THERAPEUTICS INC
CENTRAL INDEX KEY: 0001105533
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 562110007
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4233 TECHNOLOGY DR
CITY: DURHAM
STATE: NC
ZIP: 27704
BUSINESS PHONE: 9192876300
MAIL ADDRESS:
STREET 1: 4233 TECHNOLOGY DR
CITY: DURHAM
STATE: NC
ZIP: 27704
FORMER COMPANY:
FORMER CONFORMED NAME: MERIX BIOSCIENCE INC
DATE OF NAME CHANGE: 20000207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Krol Igor
CENTRAL INDEX KEY: 0001676568
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35443
FILM NUMBER: 17504050
MAIL ADDRESS:
STREET 1: C/O ARGOS THERAPEUTICS, INC.
STREET 2: 4233 TECHNOLOGY DRIVE
CITY: DURHAM
STATE: NC
ZIP: 27704
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2016-12-31
0
0001105533
ARGOS THERAPEUTICS INC
ARGS
0001676568
Krol Igor
C/O ARGOS THERAPEUTICS, INC.
4233 TECHNOLOGY DRIVE
DURHAM
NC
27704
1
0
0
0
Common Stock
2016-12-31
4
A
0
1785
0
A
3874
D
The reporting person has received a fully vested stock award for shares of the Company's common stock. For calendar year 2016, the Company has elected to make common stock awards in lieu of cash payments of director fees otherwise payable under the director compensation policy. The number of shares of common stock awarded represent the quotient of (A) such director fees divided by (B) the Company's closing stock price on the date awarded, rounded down to the nearest whole share of common stock.
/s/ Lori R. Harrelson, attorney-in-fact
2017-01-04